Papers - MATSUKI Kota
-
The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing's disease.
Hiroshi Murakami, Takeshi Nigawara, Satoru Sakihara, Kazunori Kageyama, Maki Yamashita, Kota Matsuki, Jutaro Tanabe, Jun Matsui, Naoki Tamasawa, Toshihiro Suda
Endocrine journal 57 ( 3 ) 267 - 272 2010.3
-
HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia
GUAN Jing-Zhi, TAMASAWA Naoki, MURAKAMI Hiroshi, MATSUI Jun, TANABE Jutaro, MATSUKI Kota, YAMASHITA Maki, SUDA Toshihiro
Journal of atherosclerosis and thrombosis 15 ( 1 ) 20 - 25 2008.2
-
Additional effect in reduction of albuminuria due to the combination therapy of angiotensin-converting-enzyme inhibitor and angiotensin II type 1 receptor blocker in type 2 diabetic patients with the angiotensinogen 235T allele
Matsui Jun, Ogawa Yoshiji, Tamasawa Naoki, Yamashita Maki, Matsuki Kohta, Tanabe Jutaro, Murakami Hiroshi, Suda Toshihiro
Hirosaki Medical Journal 59 ( 2 ) 59 - 64 2008
-
Nicorandil, ATP-sensitive K<SUP>+</SUP> channel opener, does not interfere with sulfonylureas and nateglinide in patients with type 2 diabetes
Matsuki Kota, Tanabe Jutaro, Yanagimachi Miyuki, Murakami Hiroshi, Tando Yusuke, Matsui Jun, Ogawa Yoshiji, Tamasawa Naoki, Suda Toshihiro
Shinzo 39 ( 8 ) 715 - 719 2007
-
Clinical characteristics of Japanese youth-onset type 2 diabetes with ketonuria.
Jun Matsui, Naoki Tamasawa, Jutaro Tanabe, Nobuhiko Kasai, Hiroshi Murakami, Kota Matsuki, Toshihiro Suda
Diabetes research and clinical practice 70 ( 3 ) 235 - 8 2005.12